Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Paediatric Respiratory Reviews|February 14, 2006
Paediatricians and the pharmaceutical industry: an industry perspective of the challenges aheadDavid A Leather, Sarah C Davis
The International Journal of Pharmacy Practice|June 27, 2020
Community pharmacy: a crucial enabler in creating the effectiveness study environment in the Salford Lung StudiesDavid A Leather, Steve Howard, Gerry Haydock, et al.
Advances in Therapy|January 14, 2020
Real-World Data and Randomised Controlled Trials: The Salford Lung StudyDavid A Leather, Rupert Jones, Ashley Woodcock, et al.
Respiratory Research|August 4, 2019
Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?David A Leather, Louisa Yates, Henrik Svedsater, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 5, 2018
Effectiveness of fluticasone furoate/vilanterol versus fluticasone propionate/salmeterol on asthma control in the Salford Lung StudyLoretta Jacques, Nawar Diar Bakerly, John P New, et al.
The European Respiratory Journal|February 23, 2018
Effectiveness <i>versus</i> efficacy trials in COPD: how study design influences outcomes and applicabilityAshley Woodcock, Isabelle Boucot, David A Leather, et al.
Pharmacoepidemiology and Drug Safety|August 7, 2019
Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial dataMatthew Sperrin, David J Webb, Pinal Patel, et al.
Respiratory Medicine|July 29, 2018
Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung StudyHenrik Svedsater, Rupert Jones, Nick Bosanquet, et al.
Respiratory Medicine|February 2, 2019
Benefit and safety of fluticasone furoate/vilanterol in the Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD) according to baseline patient characteristics and treatment subgroupsNawar Diar Bakerly, Ashley Woodcock, Susan Collier, et al.
Trials|September 18, 2020
Patient and healthcare professional experiences of the Salford Lung Studies: qualitative insights for future effectiveness trialsKim Gemzoe, Rebecca Crawford, Ann Caress, et al.
Pageof 2